Latest Articles
- Using C-reactive protein to assess cardiovascular disease risk
CRP is now a recognized cardiac test. But who should he tested?
- In-hospital initiation of statins: Taking advantage of the ‘teachable moment’
For a variety of reasons, starting a statin in the hospital increases long-term compliance.
- Withholding nutrition at the end of life: Clinical and ethical issues
The decision to withhold or withdraw enteral or parenteral nutrition at the end of life should be based on medical need, in collaboration with the family and patient, if possible.
- Staphylococcus aureus bacteremia: Using echocardiography to guide length of therapy
Empiric long-term antibiotic therapy is no longer uniformly recommended for all cases of S aureus bacteremia, although experts disagree about the optimal length of therapy.
- The Lescol Intervention Prevention Study (Lips)
The trial showed a significant reduction in cardiac events in patients who received a statin drug immediately after a successful percutaneous coronary intervention. Currently, this is seldom done.
- Proteinuria: How to evaluate an important finding
Proteinuria should be taken seriously, even in outpatients without symptoms.
- Atrial fibrillation: Rate control is as good as rhythm control for some, but not all
Many clinicians are questioning the need to restore or maintain sinus rhythm in atrial fibrillation. What did four recent trials show ?
Raising an isolated low HDL-C level: Why, how, and when?No current therapy is optimal, but many can modestly increase HDL-C. The decision to treat depends on the patient’s risk for coronary disease.